Skip to main content

Publications

Patents

Kim YH. 2023. Compositions and Methods for Treating or Preventing Neurodegenerative diseases (SENP1 Inhibition). USPTO Application # PCT-US2023-025507 (WO2023-244772).

Julie Andersen and Kim YH. Low dose Lithium in the treatment or Prophylaxis of Parkinson’s disease. 2013 USPTO patent # US 20130017274 A1.

Works in progress

The inhibition of SUMO-protease 1 (SENP1) prevents and reverses Parkinson’s disease pathology in PFF-injected mice. (In preparation). †: equal contribution.

Verma DK, Ghosh A, Seo BA, Ofori K, Cabrera G, Lee EH, Seo JB, Ko HS and Kim YH. The inhibition of SUMO-protease 1 (SENP1) prevents and reverses Parkinson’s disease pathology in PFF-injected mice. (In preparation).

Lazzara CA, Caviness-Jackson J, Janezic E, Wheeler DB, Rosikon KD, Verma DK, Lawal H,Seo JB and Kim YH. A modified natural antioxidant compound reverses neurotoxin-induced Parkinson’s disease pathology in flies and mice. Antioxidants (In the process of submission)

Stangl M, Martinez A, Verma DK, Kwon I, and Kim YH. The combined 410nm and Infra-Red light effectively suppresses bacterial survival under the realistic conditions. Microorganism (in the process of submission)

Chu T, Collado M, IzquierdoS, Cooper E, Shajpaul K, James CP, McGriff S, Wheeler DB, Ofori K, Chow HM, Kim YH, Liyun Wang LY. Combined Senolytics and 11 weeks treadmill running reversed the declining of bone tissue mineral density in aged mice with Parkinson’s disease. J. of Orthopaedic Research (in press).

Oh IT†, Kim YH†, Jeong SH, Kim SC, Kim YK and Chae KS. Magnetic sense-dependent probabilistic decision-making in humans. Frontiers in Neuroscience (Under 2nd review).

Published Works

  • Ofori K, Ghosh A, Verma DK, Wheeler D, Cabrera G, Seo J-B, Kim Y-H. A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice. International Journal of Molecular Sciences. 2023; 24(18):14278. https://doi.org/10.3390/ijms241814278.
  • Martinez A†, Hernandez-Quijada K†, Ghosh A†, Cabrera G, Scott D, Aikins A, Kwon I and Kim YH. The combination of Violet light and Infra-Red or Violet light only suppresses the survival of regular and multiple-drug resistant bacterial strains. J. Photochem & Photobiol. 2023 Apr (14),100167. DOI: 10.1016/j.jpap.2023.100167
  • Ghosh AA, Verma DK, Cabrera G, Ofori K, Hernandez-Quijada K, Kim JK, Chung JH, Moore M, Moon SH, Seo JB, Kim YH. A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models. Int J Mol Sci. 2022 Apr 12;23(8). doi: 10.3390/ijms23084262. PubMed PMID: 35457082.
  • Verma DK†, Seo BA†, Ghosh A, Ma SX, Hernandez-Quijada K, Andersen JK, Ko HS and Kim YH. Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson’s disease models. Cells. 2021 Jul 5; 10(7):1694. PMID: 34359864. †: equal contribution.
  • Verma DK, Ghosh A, Ruggiero L, Cartier E, Janezic EM, Williams D, Jung EJ, Moore M, Seo JB, and Kim YH. The SUMO conjugase Ubc9 protects Dopaminergic cells from cytotoxicity and enhances the stability of α-synuclein in Parkinson’s disease models. eNeuro. 2020 Sept 4, 0134-20. PMID: 32887693
  • Choi SM, Chung JH, Nam MH, Bang EJ, Moon HY, Hong KS, Kim YH, Seo JB, and Chi SC. Elevated Aldolase 1A, retrogene 1 expression induces cardiac apoptosis in rat experimental autoimmune myocarditis model. Canadian Journal of Physiol & Pharmacol. 2020 Jun;98(6):373-382. PMID: 31999472
  • Cartier E, Garcia-Olivares J, Janezic EM, Viana J, Moore M, Lin ML, Caplan JL, Torres G, and Kim YH. The SUMO conjugase Ubc9 delays the degradation of Dopamine Transporter, enhancing its cell surface level and dopamine uptake. Frontiers in Cellular Neuroscience. 2019 Feb 8, 13(35):1-23. PMID:30828290
  • Chae KS and Kim YH. Potential impact of geomagnetic field in transcranial magnetic stimulation for the treatment of neurodegenerative diseases. Frontiers in Human Neuroscience. 2017 Sep, 478(11):1-5. Review. PMID: 29021752
  • Janezic EM, Caviness J, Kanda GS, Davis XD, and Kim YH. Commercially available pesticides cause additive or synergistic damages in dopaminergic cells: Relevance for Parkinson’s disease pathology. Annals of Neurodegenerative disorders. 2016 1(2):1010:1-9.
  • Lazzara CL and Kim YH. Potential application of Lithium in Parkinson’s and other neurodegenerative diseases. Frontiers in Neuroscience. 2015 Oct 27:9:403. review. PMID: 26578864
  • Lazzara CL, Riley RR, Rane A, Andersen JK and Kim YH. The combination of lithium and L-dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) in mice: relevance for Parkinson’s disease therapy. Brain Res. 2015 Jul, 1622:127-136. PMID: 26119916
  • Lieu C, Dewey C, Chinta S, Rane A, Rajagopolan S, Batir S, Kim YH, Andersen JK. Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model. Brain Res. 2014 Dec, 27;1591:111-117. PMID: 25452026
  • Kim YH, Rane A, Lussier S, and Andersen JK. Lithium protects against oxidative stress-mediated cell death in alpha-synuclein over-expressing in vitro and in vivo models of Parkinson’s disease. J. Neurosci Res. 2011 89(10):1666-75. PMID: 21710541
  • Kim YH, Lussier S, Rane A, Choi SW, and Andersen JK. Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 2011 13;172:379-86. PMID: 21055449
  • Satre D, Kim YH, and Corbitt C. Androgen receptor location in the Dark-eyed Junco using a probe for in situ hybridization histochemistry generated from zebra finch cDNA. J. Neuroscience Methods 2011 30;201(1):180-4.
  • Naurin S, Hansson B, Hasselquist D, Kim YH, and Bensch S. The sex-biased brain: sexual dimorphism in gene expression in two species of songbirds. BMC Genomics 2011 Jan; 14;12(1):37.
  • Itoh Y, Replogle K, Kim YH, Wade J, Clayton DF, and Arnold AP. Sex bias and dosage compensation in the zebra finch versus chicken genomes: general and specialized patterns among birds. Genome Research. 2010 20(4):512-8.
  • Dragich JM, Kim YH, Arnold AP, Schanen CN. Differential distribution of the Mecp2 splice variants in the postnatal mouse brain. J Comp Neurol. 2007 Feb 2;501(4):526-542.
  • Kim YH, Arnold AP. Expression of NGF and trkA mRNA in song control and other regions of the zebra finch brain. Neurosci. Lett. 2006 Dec 1;409(2):151-6.
  • Kim YH, Peregrine J, Arnold AP. The distribution of expression of doublecortin (DCX) mRNA and protein in zebra finch brain. Brain Research. 2006 Aug 23;1106(1):189-96.
  • Kim YH, Arnold AP. Distribution and onset of retinaldehyde dehydrogenase (zRalDH) expression in the zebra finch brain: lack of sex difference in HVC and RA at early posthatch ages. J. Neurobiol. 2005 Dec;65(3):260-26
  • Kim YH, Perlman WR, Arnold AP. Expression of androgen receptor mRNA in the zebra finch song system: developmental regulation by estrogen. J Comp Neurol. 2004 Feb 16;469(4):535-47.
  • Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, Ganz T. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol. 2001 Nov;8(6):1064-9.
  • Cole AM, Kim YH, Tahk S, Hong T, Weis P, Waring AJ, Ganz T. Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett. 2001 Aug 24;504(1-2):5-10.
  • Cole AM, Shi J, Ceccarelli A, Kim YH, Park A, Ganz T. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood. 2001 Jan 1;97(1):297-304.
  • Saldanha CJ, Tuerk MJ, Kim YH, Fernandes AO, Arnold AP, Schlinger BA. Distribution and regulation of telencephalic aromatase expression in the zebra finch revealed with a specific antibody. J Comp Neurol. 2000 Aug 7;423(4):619-30.